tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AZN Stock Latest News

MSFT, CRM, ORCL: Why Evercore Names These 3 Software Stocks as ‘Top Picks for 2026’
Market NewsMSFT, CRM, ORCL: Why Evercore Names These 3 Software Stocks as ‘Top Picks for 2026’
1d ago
AZN
CRM
AstraZeneca Targets Chemo-Ineligible Lung Cancer Patients With New Osimertinib Trial
PremiumCompany Announcements
AstraZeneca Targets Chemo-Ineligible Lung Cancer Patients With New Osimertinib Trial
2d ago
AZN
AstraZeneca Moves CAR-T Into Autoimmune Diseases, Adding Long-Term Upside to AZN’s Pipeline
PremiumCompany Announcements
AstraZeneca Moves CAR-T Into Autoimmune Diseases, Adding Long-Term Upside to AZN’s Pipeline
2d ago
AZN
AstraZeneca says to end U.S. commercial sales of Andexxa
PremiumThe Fly
AstraZeneca says to end U.S. commercial sales of Andexxa
2d ago
AZN
Government deals lift overhang on pharma group, says BofA
PremiumThe Fly
Government deals lift overhang on pharma group, says BofA
2d ago
AZN
BMY
AstraZeneca trial of docetaxel, Imfinzi did not meet primary endpoint of OS
PremiumThe FlyAstraZeneca trial of docetaxel, Imfinzi did not meet primary endpoint of OS
2d ago
AZN
Mixed Bag for AZN Stock: AstraZeneca’s Enhertu Wins FDA Breakthrough, Imfinzi Misses Trial Goal
Premium
Market News
Mixed Bag for AZN Stock: AstraZeneca’s Enhertu Wins FDA Breakthrough, Imfinzi Misses Trial Goal
2d ago
AZN
AstraZeneca, Daiichi Sankyo granted breakthrough therapy designation for Enhertu
Premium
The Fly
AstraZeneca, Daiichi Sankyo granted breakthrough therapy designation for Enhertu
2d ago
AZN
AstraZeneca, Daiichi Sankyo dose firs patient in DESTINY-Endometrial02 trial
PremiumThe Fly
AstraZeneca, Daiichi Sankyo dose firs patient in DESTINY-Endometrial02 trial
2d ago
AZN
Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports
PremiumThe Fly
Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports
5d ago
AZN
BMY
Niowave expands global supply agreement with AstraZeneca for Actinium-225
PremiumThe Fly
Niowave expands global supply agreement with AstraZeneca for Actinium-225
6d ago
AZN
TROPION-Lung17: New Phase III Lung Cancer Trial Adds Medium-Term Upside Potential for AstraZeneca and Daiichi Sankyo
PremiumCompany Announcements
TROPION-Lung17: New Phase III Lung Cancer Trial Adds Medium-Term Upside Potential for AstraZeneca and Daiichi Sankyo
6d ago
AZN
AstraZeneca Targets Costly C. Diff Recurrence With New Antibody Trial
PremiumCompany AnnouncementsAstraZeneca Targets Costly C. Diff Recurrence With New Antibody Trial
6d ago
AZN
AstraZeneca’s AZD1163 Trial Adds Quiet Option Value in Rheumatoid Arthritis
Premium
Company Announcements
AstraZeneca’s AZD1163 Trial Adds Quiet Option Value in Rheumatoid Arthritis
6d ago
AZN
AstraZeneca’s AZD5004 Obesity Trial Edges Forward, Raising New Questions for Investors
Premium
Company Announcements
AstraZeneca’s AZD5004 Obesity Trial Edges Forward, Raising New Questions for Investors
6d ago
AZN
AstraZeneca Strengthens China Rare-Disease Position With New Real-World PNH Study Update
PremiumCompany Announcements
AstraZeneca Strengthens China Rare-Disease Position With New Real-World PNH Study Update
6d ago
AZN
AstraZeneca, Daiichi Sankyo get EMA validation of Datroway Type II Variation MAA
PremiumThe Fly
AstraZeneca, Daiichi Sankyo get EMA validation of Datroway Type II Variation MAA
6d ago
AZN
Salesforce’s Agentforce Life Sciences Gains Traction with Another Healthcare Provider Onboard
PremiumMarket News
Salesforce’s Agentforce Life Sciences Gains Traction with Another Healthcare Provider Onboard
7d ago
AZN
CRM
UK’s $49 Billion R&D Plan Puts Quantum Tech on Investors’ Radar
PremiumMarket News
UK’s $49 Billion R&D Plan Puts Quantum Tech on Investors’ Radar
7d ago
AZN
GSK
Compugen and AstraZeneca agree to monetize rilvegostomig future royalties
PremiumThe FlyCompugen and AstraZeneca agree to monetize rilvegostomig future royalties
7d ago
AZN
CGEN
AstraZeneca’s Saphnelo approved in EU for subcutaneous self-admin
Premium
The Fly
AstraZeneca’s Saphnelo approved in EU for subcutaneous self-admin
8d ago
AZN
AstraZeneca says Enhertu plus pertuzumab approved by FDA for 1st line treatment
Premium
The Fly
AstraZeneca says Enhertu plus pertuzumab approved by FDA for 1st line treatment
9d ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >